Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
4.150
-0.130 (-3.04%)
At close: Apr 28, 2026, 4:00 PM EDT
4.190
+0.040 (0.96%)
After-hours: Apr 28, 2026, 7:15 PM EDT
Arbutus Biopharma Market Cap
Arbutus Biopharma has a market cap or net worth of $817.30 million as of April 28, 2026. Its market cap has increased by 35.94% in one year.
Market Cap
817.30M
Enterprise Value
731.00M
1-Year Change
35.94%
Ranking
Category
Stock Price
$4.15
Market Cap Chart
Since December 31, 2009, Arbutus Biopharma's market cap has increased from $47.50M to $817.30M, an increase of 1,620.63%. That is a compound annual growth rate of 19.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 811.20M | -12.31% |
| Dec 31, 2025 | 925.10M | 49.31% |
| Dec 31, 2024 | 619.60M | 47.81% |
| Dec 29, 2023 | 419.20M | 14.98% |
| Dec 30, 2022 | 364.60M | -30.71% |
| Dec 31, 2021 | 526.20M | 74.59% |
| Dec 31, 2020 | 301.40M | 90.76% |
| Dec 31, 2019 | 158.00M | -25.65% |
| Dec 31, 2018 | 212.50M | -23.56% |
| Dec 29, 2017 | 278.00M | 106.85% |
| Dec 30, 2016 | 134.40M | -44.65% |
| Dec 31, 2015 | 242.80M | -28.19% |
| Dec 31, 2014 | 338.10M | 196.58% |
| Dec 31, 2013 | 114.00M | 89.05% |
| Dec 31, 2012 | 60.30M | 289.03% |
| Dec 30, 2011 | 15.50M | -68.04% |
| Dec 31, 2010 | 48.50M | 2.11% |
| Dec 31, 2009 | 47.50M | - |
View and export this data all the way back to 2009.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 859.49M |
| MeiraGTx Holdings | 854.30M |
| Theravance Biopharma | 847.57M |
| MannKind | 833.75M |
| Crescent Biopharma | 823.70M |
| ARS Pharmaceuticals | 823.17M |
| Kura Oncology | 821.94M |
| SELLAS Life Sciences Group | 800.94M |